Viewing Study NCT00541450


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-01-07 @ 12:10 AM
Study NCT ID: NCT00541450
Status: COMPLETED
Last Update Posted: 2017-05-12
First Post: 2007-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01-15
Start Date Type: ACTUAL
Primary Completion Date: 2010-01-08
Primary Completion Date Type: ACTUAL
Completion Date: 2010-01-16
Completion Date Type: ACTUAL
First Submit Date: 2007-10-05
First Submit QC Date: None
Study First Post Date: 2007-10-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-01-13
Results First Submit QC Date: None
Results First Post Date: 2011-04-14
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-07
Last Update Post Date: 2017-05-12
Last Update Post Date Type: ACTUAL